The U.S. Government Accountability Office (GAO) released a report on the results of the study that analyzes the characteristics of hospitals that participate or do not participate in the 340B drug discount program. The GAO conducted this study due to the sixty percent increase from 2011 to 2016 in program participation, as well as the impact of Medicaid expansion on 340B participation.
The study was focused on three of the six hospital types, as they accounted for ninety five percent of U.S. hospitals participating in the 340B program. These three hospital types include:
- Critical Access Hospitals (CAH)
- Sole Community Hospitals (SCH)
- General Acute Care Hospitals (Also Known As 340B DSH)
The full report can be found on the U.S. Government Accountability Office website, https://www.gao.gov/products/GAO-18-521R.
Posted by the AHA Resource Center, (312) 422-2050, rc@aha.org.
Filed under: Ambulatory care, Ambulatory care facilities, Hospitals, Pharmaceuticals, Posted by Rachel Wedeward, Uncategorized | Tagged: 340B drug discount program, Outpatient care |
American Hospital Association Resource Center Blog 